These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

205 related items for PubMed ID: 19006538

  • 21. Long-term results of a clinical trial of nadolol with or without isosorbide mononitrate for primary prophylaxis of variceal bleeding in cirrhosis.
    Merkel C, Marin R, Sacerdoti D, Donada C, Cavallarin G, Torboli P, Amodio P, Sebastianelli G, Bolognesi M, Felder M, Mazzaro C, Gatta A.
    Hepatology; 2000 Feb; 31(2):324-9. PubMed ID: 10655253
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Acute hemodynamic response to beta-blockers and prediction of long-term outcome in primary prophylaxis of variceal bleeding.
    Villanueva C, Aracil C, Colomo A, Hernández-Gea V, López-Balaguer JM, Alvarez-Urturi C, Torras X, Balanzó J, Guarner C.
    Gastroenterology; 2009 Jul; 137(1):119-28. PubMed ID: 19344721
    [Abstract] [Full Text] [Related]

  • 24. Drugs plus ligation to prevent rebleeding in cirrhosis: an updated systematic review.
    Puente A, Hernández-Gea V, Graupera I, Roque M, Colomo A, Poca M, Aracil C, Gich I, Guarner C, Villanueva C.
    Liver Int; 2014 Jul; 34(6):823-33. PubMed ID: 24373180
    [Abstract] [Full Text] [Related]

  • 25. [Endoscopic ligation compared with combined treatment with nadolol and isosorbide mononitrate to prevent recurrent variceal bleeding].
    Wiest R, Lock G, Messmann H.
    Z Gastroenterol; 2002 Jul; 40(7):547-9. PubMed ID: 12122606
    [No Abstract] [Full Text] [Related]

  • 26. Prevention of recurrent esophageal variceal hemorrhage: review and current recommendations.
    Kravetz D.
    J Clin Gastroenterol; 2007 Jul; 41 Suppl 3():S318-22. PubMed ID: 17975483
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. A randomized, controlled trial of medical therapy versus endoscopic ligation for the prevention of variceal rebleeding in patients with cirrhosis.
    Patch D, Sabin CA, Goulis J, Gerunda G, Greenslade L, Merkel C, Burroughs AK.
    Gastroenterology; 2002 Oct; 123(4):1013-9. PubMed ID: 12360462
    [Abstract] [Full Text] [Related]

  • 34. Variceal bleeding : pharmacological treatment and prophylactic strategies.
    Villanueva C, Balanzó J.
    Drugs; 2008 Oct; 68(16):2303-24. PubMed ID: 18973395
    [Abstract] [Full Text] [Related]

  • 35. Endoscopic variceal ligation plus nadolol and sucralfate compared with ligation alone for the prevention of variceal rebleeding: a prospective, randomized trial.
    Lo GH, Lai KH, Cheng JS, Chen MH, Huang HC, Hsu PI, Lin CK.
    Hepatology; 2000 Sep; 32(3):461-5. PubMed ID: 10960435
    [Abstract] [Full Text] [Related]

  • 36. Variceal ligation plus nadolol compared with ligation for prophylaxis of variceal rebleeding: a multicenter trial.
    de la Peña J, Brullet E, Sanchez-Hernández E, Rivero M, Vergara M, Martin-Lorente JL, Garcia Suárez C.
    Hepatology; 2005 Mar; 41(3):572-8. PubMed ID: 15726659
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Nadolol plus spironolactone in the prophylaxis of first variceal bleed in nonascitic cirrhotic patients: A preliminary study.
    Abecasis R, Kravetz D, Fassio E, Ameigeiras B, Garcia D, Isla R, Landeira G, Dominguez N, Romero G, Argonz J, Terg R.
    Hepatology; 2003 Feb; 37(2):359-65. PubMed ID: 12540786
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Hemodynamic evaluation of the addition of isosorbide-5-mononitrate to nadolol in cirrhotic patients with insufficient response to the beta-blocker alone.
    Merkel C, Sacerdoti D, Bolognesi M, Enzo E, Marin R, Bombonato G, Angeli P, Gatta A.
    Hepatology; 1997 Jul; 26(1):34-9. PubMed ID: 9214449
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.